Naomi K Tepper

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. doi request reprint Nonoral combined hormonal contraceptives and thromboembolism: a systematic review
    Naomi K Tepper
    Division of Reproductive Health, US Centers for Disease Control and Prevention, 4770 Buford Hwy, MS F 74, Atlanta, GA 30341 Electronic address
    Contraception 95:130-139. 2017
  2. doi request reprint Superficial venous disease and combined hormonal contraceptives: a systematic review
    Naomi K Tepper
    Division of Reproductive Health, US Centers for Disease Control and Prevention, 4770 Buford Hwy, MS F 74, Atlanta, GA 30341, USA Electronic address
    Contraception 94:275-9. 2016
  3. doi request reprint Safety of intrauterine devices among women with HIV: a systematic review
    Naomi K Tepper
    Division of Reproductive Health, US Centers for Disease Control and Prevention, 4770 Buford Hwy, MS F 74, Atlanta, GA 30341 Electronic address
    Contraception 94:713-724. 2016
  4. doi request reprint Safety of hormonal contraceptives among women with migraine: A systematic review
    Naomi K Tepper
    Division of Reproductive Health, US Centers for Disease Control and Prevention, 4770 Buford Hwy, MS F 74, Atlanta, GA, 30341 Electronic address
    Contraception 94:630-640. 2016
  5. doi request reprint Progestin-only contraception and thromboembolism: A systematic review
    Naomi K Tepper
    Division of Reproductive Health, US Centers for Disease Control and Prevention, Atlanta, GA, 30341, USA Electronic address
    Contraception 94:678-700. 2016
  6. doi request reprint Combined hormonal contraceptive use among breastfeeding women: an updated systematic review
    Naomi K Tepper
    Division of Reproductive Health, US Centers for Disease Control and Prevention, Atlanta, GA 30341 Electronic address
    Contraception 94:262-74. 2016
  7. doi request reprint Blood pressure measurement prior to initiating hormonal contraception: a systematic review
    Naomi K Tepper
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Contraception 87:631-8. 2013
  8. doi request reprint Retention of intrauterine devices in women who acquire pelvic inflammatory disease: a systematic review
    Naomi K Tepper
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Contraception 87:655-60. 2013
  9. doi request reprint Physical examination prior to initiating hormonal contraception: a systematic review
    Naomi K Tepper
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Contraception 87:650-4. 2013
  10. doi request reprint Laboratory screening prior to initiating contraception: a systematic review
    Naomi K Tepper
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Contraception 87:645-9. 2013

Collaborators

Detail Information

Publications38

  1. doi request reprint Nonoral combined hormonal contraceptives and thromboembolism: a systematic review
    Naomi K Tepper
    Division of Reproductive Health, US Centers for Disease Control and Prevention, 4770 Buford Hwy, MS F 74, Atlanta, GA 30341 Electronic address
    Contraception 95:130-139. 2017
    ....
  2. doi request reprint Superficial venous disease and combined hormonal contraceptives: a systematic review
    Naomi K Tepper
    Division of Reproductive Health, US Centers for Disease Control and Prevention, 4770 Buford Hwy, MS F 74, Atlanta, GA 30341, USA Electronic address
    Contraception 94:275-9. 2016
    ..Little is known about whether use of CHCs by women with superficial venous disease may further elevate the risk of VTE...
  3. doi request reprint Safety of intrauterine devices among women with HIV: a systematic review
    Naomi K Tepper
    Division of Reproductive Health, US Centers for Disease Control and Prevention, 4770 Buford Hwy, MS F 74, Atlanta, GA 30341 Electronic address
    Contraception 94:713-724. 2016
    ..However, it is not known whether use of intrauterine devices (IUDs) among women with advanced HIV disease poses an increased risk of pelvic infection or HIV progression and transmission...
  4. doi request reprint Safety of hormonal contraceptives among women with migraine: A systematic review
    Naomi K Tepper
    Division of Reproductive Health, US Centers for Disease Control and Prevention, 4770 Buford Hwy, MS F 74, Atlanta, GA, 30341 Electronic address
    Contraception 94:630-640. 2016
    ..Combined oral contraceptives (COCs) are also associated with an increased risk of ischemic stroke. Use of hormonal contraception among women with migraine might further elevate the risk of stroke among women of reproductive age...
  5. doi request reprint Progestin-only contraception and thromboembolism: A systematic review
    Naomi K Tepper
    Division of Reproductive Health, US Centers for Disease Control and Prevention, Atlanta, GA, 30341, USA Electronic address
    Contraception 94:678-700. 2016
    ..Women with medical conditions associated with increased risk for thrombosis generally should not use estrogen-containing contraceptives; however, less is known about progestin-only contraceptives (POCs) and thrombosis risk...
  6. doi request reprint Combined hormonal contraceptive use among breastfeeding women: an updated systematic review
    Naomi K Tepper
    Division of Reproductive Health, US Centers for Disease Control and Prevention, Atlanta, GA 30341 Electronic address
    Contraception 94:262-74. 2016
    ..Contraception is important for women who are postpartum, including those who are breastfeeding. Use of combined hormonal contraceptives (CHCs) may affect breastfeeding performance and infant health outcomes...
  7. doi request reprint Blood pressure measurement prior to initiating hormonal contraception: a systematic review
    Naomi K Tepper
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Contraception 87:631-8. 2013
    ..This review was conducted to evaluate the evidence regarding whether blood pressure should be measured prior to initiating hormonal contraceptives...
  8. doi request reprint Retention of intrauterine devices in women who acquire pelvic inflammatory disease: a systematic review
    Naomi K Tepper
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Contraception 87:655-60. 2013
    ..This review was conducted to evaluate the evidence regarding whether an IUD should be retained or removed if a woman develops PID...
  9. doi request reprint Physical examination prior to initiating hormonal contraception: a systematic review
    Naomi K Tepper
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Contraception 87:650-4. 2013
    ..This review was conducted to evaluate the evidence regarding outcomes among women with and without physical examination prior to initiating hormonal contraceptives...
  10. doi request reprint Laboratory screening prior to initiating contraception: a systematic review
    Naomi K Tepper
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Contraception 87:645-9. 2013
    ..This review was conducted to evaluate the evidence regarding health outcomes among women with and without laboratory testing to identify certain medical conditions prior to initiating contraceptives...
  11. doi request reprint Use of a checklist to rule out pregnancy: a systematic review
    Naomi K Tepper
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Contraception 87:661-5. 2013
    ..The World Health Organization has developed a list of criteria to assess pregnancy status. This review was conducted to evaluate the evidence regarding these criteria in excluding pregnancy...
  12. doi request reprint Hemoglobin measurement prior to initiating copper intrauterine devices: a systematic review
    Naomi K Tepper
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Contraception 87:639-44. 2013
    ..Women using copper intrauterine devices (IUDs) frequently experience bleeding abnormalities. This review was conducted to evaluate the evidence regarding whether hemoglobin levels should be measured prior to copper IUD insertion...
  13. doi request reprint Singleton preterm birth: risk factors and association with assisted reproductive technology
    Naomi K Tepper
    National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Matern Child Health J 16:807-13. 2012
    ..Medical conditions were associated with an increased risk for preterm birth regardless of women's ART status. Efforts to prevent preterm births should focus on reducing modifiable risk factors...
  14. doi request reprint Safety of contraceptive use among women with peripartum cardiomyopathy: a systematic review
    Naomi K Tepper
    Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Contraception 82:95-101. 2010
    ..This systematic review examines evidence regarding the safety of contraceptive use among women with PPCM...
  15. doi request reprint Use of intrauterine devices in women with uterine anatomic abnormalities
    Naomi K Tepper
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA
    Int J Gynaecol Obstet 109:52-4. 2010
    ..To examine the evidence regarding the safety and effectiveness of intrauterine devices (IUDs) in women with uterine abnormalities...
  16. doi request reprint Use of contraceptive methods among women with endometrial hyperplasia: a systematic review
    Maura K Whiteman
    Centers for Disease Control and Prevention, Atlanta, GA 30341 3724, USA
    Contraception 82:56-63. 2010
    ..The objective of this systematic review is to evaluate the evidence for the safety of contraceptive use among women with endometrial hyperplasia...
  17. doi request reprint Drug interactions between hormonal contraceptives and psychotropic drugs: a systematic review
    Erin N Berry-Bibee
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA, USA Electronic address
    Contraception 94:650-667. 2016
    ..To examine whether the co-administration of hormonal contraceptives (HC) and psychotropic drugs commonly used to treat anxiety and/or depression results in safety or efficacy concerns for either drug...
  18. doi request reprint U.S. Selected Practice Recommendations for Contraceptive Use, 2016
    Kathryn M Curtis
    Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion
    MMWR Recomm Rep 65:1-66. 2016
    ..This report is not intended to be a substitute for professional medical advice for individual patients. Persons should seek advice from their health care providers when considering family planning options. ..
  19. doi request reprint Use of combined hormonal contraceptives among women with migraines and risk of ischemic stroke
    Steven W Champaloux
    Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA
    Am J Obstet Gynecol . 2016
    ..However, little is known about whether there are any joint effects of migraine and hormonal contraceptives on risk of stroke...
  20. doi request reprint Respiratory illness hospitalizations among pregnant women during influenza season, 1998-2008
    Angela Martin
    Department of Gynecology and Obstetrics, Emory University, 1648 Pierce Drive, Atlanta, GA 30322, USA
    Matern Child Health J 17:1325-31. 2013
    ..Efforts to minimize influenza morbidity, including universal vaccination and early antiviral therapy should be promoted among all pregnant women. ..
  21. doi request reprint Intrauterine device use among women with uterine fibroids: a systematic review
    Lauren B Zapata
    Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Contraception 82:41-55. 2010
    ....
  22. doi request reprint U.S. Medical Eligibility Criteria for Contraceptive Use, 2016
    Kathryn M Curtis
    Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, CDC, Atlanta, Georgia
    MMWR Recomm Rep 65:1-103. 2016
    ..This report is not intended to be a substitute for professional medical advice for individual patients. Persons should seek advice from their health care providers when considering family planning options. ..
  23. doi request reprint The safety of intrauterine devices in breastfeeding women: a systematic review
    Erin N Berry-Bibee
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA, USA Electronic address
    Contraception 94:725-738. 2016
    ..To investigate levonorgestrel (LNG)-releasing and copper-bearing (Cu) intrauterine device (IUD) safety among breastfeeding women and, for Cu-IUD use, breastfeeding performance and infant health...
  24. doi request reprint Contraceptive Use Among Women With Medical Conditions in a Nationwide Privately Insured Population
    Steven W Champaloux
    Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia
    Obstet Gynecol 126:1151-9. 2015
    ..To examine contraceptive use among women with selected medical conditions...
  25. doi request reprint U.S. selected practice recommendations for contraceptive use, 2013
    Naomi K Tepper
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, Georgia
    J Womens Health (Larchmt) 23:108-11. 2014
    ....
  26. doi request reprint Postpartum intrauterine device insertion and postpartum tubal sterilization in the United States
    Maura K Whiteman
    Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Am J Obstet Gynecol 206:127.e1-7. 2012
    ..The purpose of this study was to estimate US rates of postpartum intrauterine device (IUD) insertion and postpartum tubal sterilization...
  27. doi request reprint Intrauterine contraceptive insertion postabortion: a systematic review
    Maria W Steenland
    Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Contraception 84:447-64. 2011
    ..This review was conducted to evaluate the evidence regarding the safety and effectiveness of intrauterine device (IUD) insertion immediately following spontaneous or induced abortion...
  28. pmc Using a checklist to assess pregnancy in teenagers and young women
    Maura K Whiteman
    Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, and the Department of Gynecology and Obstetrics, Emory University, School of Medicine, Atlanta, Georgia
    Obstet Gynecol 123:777-84. 2014
    ..We examined the performance of a checklist based on criteria recommended in family planning guidance documents to assist health care providers in assessing pregnancy in a sample of U.S. teenagers and young women...
  29. doi request reprint Adaptation of the World Health Organization's Selected Practice Recommendations for Contraceptive Use for the United States
    Kathryn M Curtis
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Contraception 87:513-6. 2013
    ..The WHO guidance includes evidence-based recommendations on common, yet sometimes complex, contraceptive management questions...
  30. doi request reprint Pregnancies after hysteroscopic sterilization: a systematic review
    Tara P Cleary
    Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, GA 30303, USA
    Contraception 87:539-48. 2013
    ..Newer approaches to female sterilization, including hysteroscopic methods, have been approved for use in the United States since 2002. Little is known about the occurrence and timing of pregnancies after these procedures...
  31. doi request reprint U.S. medical eligibility criteria for contraceptive use, 2010
    Kathryn M Curtis
    Division of Reproductive Health, Centers for Disease Control and Prevention, 4770 Buford Highway NE, Atlanta, GA 30341, USA
    J Womens Health (Larchmt) 20:825-8. 2011
    ..Most women, even those with medical conditions, can safely use most methods of contraception...
  32. doi request reprint Putting risk into perspective: the US medical eligibility criteria for contraceptive use
    Kathryn M Curtis
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Rev Endocr Metab Disord 12:119-25. 2011
    ..Most women, even women with medical conditions, can safely use highly effective methods of contraception and promoting their use will further efforts to reduce unintended pregnancy...
  33. doi request reprint Postpartum venous thromboembolism: incidence and risk factors
    Naomi K Tepper
    Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion and the Division of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia
    Obstet Gynecol 123:987-96. 2014
    ..To calculate incidence of postpartum venous thromboembolism by week after delivery and to examine potential risk factors for venous thromboembolism overall and at different times during the postpartum period...
  34. ncbi request reprint Updated Guidance for Safe and Effective Use of Contraception
    Naomi K Tepper
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, Georgia
    J Womens Health (Larchmt) 25:1097-1101. 2016
    ..The recommendations aim to reduce certain barriers to contraception and thus help women, men, and couples to control timing of pregnancies...
  35. ncbi request reprint Safety of seasonal influenza and influenza A (H1N1) 2009 monovalent vaccines in pregnancy
    Pedro L Moro
    Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, MS D26, Atlanta, GA 30333, USA
    Expert Rev Vaccines 11:911-21. 2012
    ..This review summarizes US and international safety data for influenza vaccines in pregnant women with an emphasis on 2009 H1N1 influenza vaccines...
  36. doi request reprint Co-administration of St. John's wort and hormonal contraceptives: a systematic review
    Erin N Berry-Bibee
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA, USA Electronic address
    Contraception 94:668-677. 2016
    ..This systematic review examined whether the co-administration of SJW and hormonal contraceptives leads to significant safety or efficacy concerns...
  37. doi request reprint Developing Federal Clinical Care Recommendations for Women
    Emily M Godfrey
    Division of Reproductive Health, CDC, Atlanta, Georgia
    Am J Prev Med 49:S6-S13. 2015
    ..The provision of family planning services has important health benefits for the U.S...
  38. doi request reprint Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women
    Yenlik A Zheteyeva
    Immunization Safety Office, Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Atlanta, GA, USA
    Am J Obstet Gynecol 207:59.e1-7. 2012
    ..We sought to characterize reports to the Vaccine Adverse Event Reporting System (VAERS) of pregnant women who received tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap)...